Back to Grants
TX
Cancer Prevention and Research Institute of Texas (CPRIT) Product Development Awards
Non-dilutive funding for companies developing innovative cancer technologies. Programs include SEED, TDDC, TTC, and TNTC supporting full lifecycle from discovery to late-stage clinical development.
About this program
Preliminary applications due April 16, 2026; full applications due July 9, 2026. CPRIT allocates approximately $70 million annually for company investments. Distributes funding through milestone-based contracts.
Eligibility
Companies developing cancer technologies who must maintain a Texas business presence (HQ, personnel, manufacturing, or clinical activity) or be willing to relocate to Texas upon award.
Funding Categories
Research Innovation